SpringWorks Therapeutics is a biopharmaceutical company focused on developing and commercializing targeted therapies for patients with rare tumors. Specializing in conditions like desmoid tumors and neurofibromatosis type 1 associated plexiform neurofibromas, we are dedicated to providing effective treatment options where none previously existed. Our commitment to innovation and urgency drives us to meet the critical needs of those battling these challenging conditions.
